Table II.
Patient Characteristics | N |
---|---|
Gender |
185 |
Male | |
Female | 82 |
Race |
155 |
White | |
Hispanic or Latino | 65 |
Black or African American | 20 |
Native Hawaiian or other Pacific Islander | 2 |
Asian | 10 |
American Indian or Alaska native | 5 |
Other | 5 |
Unknown | 5 |
CNS status |
208 |
CNS 1 | |
CNS 2 | 28 |
CNS 3 | 31 |
Testicular disease |
188 |
No | |
Yes | 6 |
NA | 73 |
Age |
88 |
<10 yrs | |
10+ yrs | 179 |
WBC |
149 |
<50,000/µl | |
50,000 – 100,000/µl | 26 |
≥100,000/ µl | 92 |
NCI risk group |
27 |
Standard risk | |
High risk | 240 |
Congenital abnormality |
65 |
Unknown | |
None | 192 |
Down syndrome | 8 |
Other | 2 |
MLL abnormality |
243 |
Negative | |
Positive | 24 |
Event type |
4 |
Died in remission | |
None (continuous complete remission) | 168 |
Relapse: marrow | 52 |
Relapse: isolated CNS | 28 |
Relapse: marrow + CNS | 8 |
Relapse: other - bones (1), marrow+lymph nodes (1), marrow+testes (2), retina (1), testes (1) Relapse: unknown site |
6 1 |